Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SL Science HoldingSLBT +24.39%12 PS Ratio is 822.50 as of Aug. 03, 2026, which is 23% below its 10-year median of 1,075.00. GuruFocus rates SLBT with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 931 Biotechnology companies, SL Science Holding ranks worse than 95.17% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, SL Science Holding's share price is $3.29.
SL Science Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00. Hence, SL Science Holding's PS Ratio for today is 822.50.
The historical rank and industry rank for SL Science Holding's PS Ratio or its related term are showing as below:
SLBT'
s PS Ratio Range Over the Past 10 Years
Min: 652.5 Med: 1075 Max: 1497.5
Current: 822.52
During the past 3 years, SL Science Holding's highest PS Ratio was 1497.50. The lowest was 652.50. And the median was 1075.00.
SLBT's PS Ratio is ranked worse than 95.17% of 931
companies
in the Biotechnology industry
Industry Median: 8.9
vs SLBT: 822.52
SL Science Holding (NAS:SLBT) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
SL Science Holding PS Ratio Related Terms
SL Science Holding PS Ratio Historical Data
* Premium members only.
The historical data trend for SL Science Holding's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SL Science Holding PS Ratio Chart
SL Science Holding Annual Data
Trend
Dec23
Dec24
Dec25
PS Ratio
0.00
0.00
0.00
SL Science Holding Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
PS Ratio
0.00
0.00
0.00
0.00
0.00
SLBT vs DMRA, BCAX, TYRA: PS Ratio Comparison
For the Biotechnology subindustry, SL Science Holding's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SL Science Holding PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SL Science Holding's PS Ratio distribution charts can be found below:
* The bar in red indicates where SL Science Holding's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
SL Science Holding's Share Price of today is $3.29.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SL Science Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
SL Science Holding (SLBT) has a PS Ratio of 822.50 as of Aug. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on SL Science Holding and its competitors. This is 23% below median its historical median of 1,075.00. Over the past decade, SL Science Holding's PS Ratio has ranged from 652.50 to 1,497.50. According to the industry distribution chart, SL Science Holding ranks #886 out of 931 companies in the Biotechnology industry, placing it in the top 95.2%.
Is SL Science Holding's PS Ratio too high?
SL Science Holding's current PS Ratio of 822.50 is 23% below median its 10-year median of 1,075.00. Over the past 10 years, this metric has ranged from a low of 652.50 to a high of 1,497.50. The Biotechnology industry median PS Ratio is 8.90. SL Science Holding's value of 822.50 is 9141.6% above this industry median. Based on the distribution chart, SL Science Holding ranks #886 out of 931 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, SL Science Holding has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does SL Science Holding's PS Ratio compare to DMRA and BCAX?
According to the Biotechnology industry distribution chart, SL Science Holding ranks #886 out of 931 companies for PS Ratio. This places SL Science Holding in the lower half of its industry. The industry median PS Ratio is 8.90. SL Science Holding's value of 822.50 is 9141.6% above this benchmark. Historically, SL Science Holding's own PS Ratio has ranged from 652.50 to 1,497.50 over the past decade. While the company's 10-year median is 1,075.00 vs. the industry median of 8.90, SL Science Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 8.90, based on 931 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SL Science Holding's current PS Ratio of 822.50 is 9141.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on SL Science Holding and its competitors. For the Biotechnology industry, the median PS Ratio is 8.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SL Science Holding's current PS Ratio is 822.50, which is 23% below median its own 10-year median of 1,075.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SL Science Holding stock overvalued right now?
SL Science Holding (SLBT) has a current PS Ratio of 822.50. The current PS Ratio is 822.50, which is 23% below median its 10-year median of 1,075.00 and 9141.6% above the Biotechnology industry median of 8.90. SL Science Holding's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For SL Science Holding (SLBT), the current PS Ratio is 822.50 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
12GF Score
Get the complete analysis for SLBT
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SLBT has been successfully added to your 
